Percutaneous Mechanical Circulatory Support Device Market Trends and Forecast
The future of the global percutaneous mechanical circulatory support device market looks promising with opportunities in the retail, automotive, food & beverage, pharmaceutical, and consumer goods markets. The global percutaneous mechanical circulatory support device market is expected to grow with a CAGR of 9.2% from 2025 to 2031. The major drivers for this market are the increasing cases of cardiac disorders, the rising demand for minimally invasive treatments, and the growing investment in healthcare infrastructure.
• Lucintel forecasts that, within the type category, vertical baler is expected to witness the highest growth over the forecast period.
• Within the end use category, pharmaceutical is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Percutaneous Mechanical Circulatory Support Device Market
The percutaneous mechanical circulatory support device market is marked by a number of emerging trends that are centered on improving efficacy, safety, and patient outcomes. These trends are being promoted by technological advancements, changing clinical practices, and increasing awareness about the complexity of acute heart failure and cardiogenic shock. The focus is on delivering individualized and less invasive support strategies.
• Miniaturization and Increased Deliverability: Devices are smaller and easier to implant percutaneously, which decreases vascular complications and increases patient comfort. It enables earlier treatment and increased application in varied patient anatomies. For example, newer generations of microaxial pumps have reduced profiles making easier insertion possible as well as a possibly lower risk of access-site bleeding.
• Better Hemocompatibility and Biocompatibility: Advances in coatings and materials work towards lessening device-associated issues like hemolysis and thrombosis, resulting in longer-lasting, more secure support. This becomes very important in support for the longer mechanical times, whether it be as bridge to recovery or transplant. More studies on more advanced biomaterials are increasingly giving better advancements in this context.
• Integration with Advanced Hemodynamic Monitoring: Many devices now track cardiac output, blood pressure, and other key hemodynamic metrics in real time. These data are being integrated with pMCS devices to enable more responsive and precise support level adjustment, thus improving patient care and potentially improving results. Advanced algorithms interpret these data to inform clinical decision.
• Greater Emphasis on Early Intervention in Cardiogenic Shock: There is emerging evidence favoring the early start of pMCS in cardiogenic shock to counteract end-organ damage and enhance survival. This movement includes the creation of protocolized programs and shock teams to enable timely assessment and device implantation. Prompted intervention can break the vicious circle of hemodynamic collapse.
• Development of Multi-Functional Devices: Some recent pMCS devices are also being developed to provide integrated circulatory and respiratory support, especially in the management of severe cardiorespiratory failure. Integration can make it easier to manage and possibly have better outcomes for difficult clinical situations. For instance, some ECMO systems are percutaneously deployable and deliver both oxygenation and hemodynamic support.
These new trends are collectively transforming the percutaneous mechanical circulatory support device market by promoting the creation of more advanced, less invasive, and patient-focused solutions. The emphasis on early intervention, improved monitoring, and decreased complications will have the potential to broaden the use of pMCS and eventually lead to better outcomes for critically ill cardiac patients.
Recent Development in the Percutaneous Mechanical Circulatory Support Device Market
Recent years have seen major advances in the percutaneous mechanical circulatory support device market, fueled by the demand for more efficient and safer means of treating acute heart failure and cardiogenic shock. These advances cut across technological innovations, changing clinical applications, and a better understanding of patient needs. The emphasis is on enhancing survival, minimizing complications, and broadening the application of pMCS.
• Micro axial Pump Technology Advancements: Progressive design and functional improvements in micro axial pumps, like the Impeller, have resulted in higher flow rates, reduced device profiles, and greater ease of use. These improvements enable improved hemodynamic support with possibly decreased risks of vascular damage and bleeding, opening their application in high-risk PCI and cardiogenic shock.
• Increased Use of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO): VA-ECMO is increasingly being seen as capable of delivering extensive cardiorespiratory support in refractory cardiogenic shock. Advances in cannulation and management strategies are enhancing outcomes and increasing its use as an invaluable instrument in critical care cardiology.
• Development of Dedicated Right Ventricular Support Devices: In appreciation of the significance of right ventricular (RV) function in global hemodynamic stability, there is increased interest and development of percutaneous devices aimed at supporting the failing RV. This is a key unmet need in patients with biventricular failure or isolated RV dysfunction.
• Interconnectedness of Artificial Intelligence (AI) and Machine Learning (ML): AI and ML algorithms are being investigated for maximizing patient selection for pMCS, determining outcomes, and informing device management. Through review of large numbers of data points, these systems have the capability to individualize therapy and facilitate better clinical decision-making in more complex cases.
• Emphasis on Device Thrombosis Mitigation Strategies: Device thrombosis is a major issue in pMCS. Recent advancements involve enhanced anticoagulation protocols, next-generation biocompatible coatings, and device design that reduces blood-device interaction, all with the goal of limiting thromboembolic complications and improving patient safety.
These fundamental advances are profoundly affecting the percutaneous mechanical circulatory support device market by providing clinicians with an expanded set of tools and approaches to care for critically ill cardiac patients. The advances in device technology, combined with the use of AI and attention to safety, are leading to better patient outcomes and an expanded role for pMCS in the treatment of severe heart failure and cardiogenic shock.
Strategic Growth Opportunities in the Percutaneous Mechanical Circulatory Support Device Market
The percutaneous mechanical circulatory support device market offers substantial strategic growth opportunities by key application, fueled by the rising incidence of acute heart failure and cardiogenic shock. Identifying precise clinical settings in which pMCS will provide measurable benefit is essential for market growth and enhanced patient outcomes.
• Early and Prophylactic Support during High-Risk PCI: Aggressive use of pMCS in patients undergoing complex, high-risk percutaneous coronary intervention has the potential to stabilize hemodynamics, permit more extensive revascularization, and possibly mitigate adverse cardiac outcomes. This is a major expansion area by enhancing procedural safety and success in complicated cases.
• Bridge to Recovery in Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMI-CS): Early use of pMCS in AMI-CS may offer essential hemodynamic support, enabling recovery of the myocardium. Identifying patients who are most likely to benefit from this "bridge to recovery" approach and maximizing device utilization presents a significant opportunity to enhance survival and long-term outcomes.
• Support Throughout High-Risk Electrophysiology Procedures: pMCS may help offer hemodynamic stability throughout complex electrophysiology procedures, like ventricular tachycardia ablation, in patients with compromised cardiac function. This use facilitates safer and more effective arrhythmia treatment that may otherwise be too risky.
• Bridge to Transplant and Destination Therapy in Advanced Heart Failure: For end-stage heart failure patients, pMCS devices can be used as a bridge to heart transplantation or as destination therapy for non-transplant candidates. Device durability and patient management advancements are increasing the application of pMCS in these chronic conditions.
• Support for Non-Cardiac Critical Illness with Secondary Cardiac Dysfunction: pMCS may be a useful tool in managing hemodynamic instability in critically ill patients with severe infections, pulmonary embolism, or other non-cardiac conditions resulting in secondary cardiac dysfunction. Identifying such applications broadens the scope of pMCS usage as more than a primary cardiac disease treatment.
These strategic growth prospects have the potential to strongly influence the percutaneous mechanical circulatory support device market by increasing its clinical utility and enhancing patient outcomes in a broader array of critical care situations. By emphasizing early intervention, aiding high-risk procedures, and addressing solutions for advanced heart failure and secondary cardiac dysfunction, the pMCS market can realize high growth and further the treatment of complex cardiovascular disorders.
Percutaneous Mechanical Circulatory Support Device Market Driver and Challenges
The percutaneous mechanical circulatory support device market is shaped by a multifaceted interplay of technological innovations, economic considerations, and regulatory environments. It is important to comprehend the drivers and challenges to manage this evolving market and drive innovation to enhance patient outcomes.
The factors responsible for driving the percutaneous mechanical circulatory support device market include:
1. Growing Incidence of Cardiovascular Diseases: The growing incidence of heart failure, acute myocardial infarction, and other cardiovascular diseases worldwide is a key driver for the need for pMCS devices. With the growing aging population and lifestyle-related risk factors, the demand for efficient hemodynamic support solutions is on the rise.
2. Technological Advances in Device Technology: Ongoing innovation resulting in smaller, more efficient, and safer pMCS devices is a key driver. Advances in pump technology, biocompatible materials, and minimally invasive delivery systems increase clinical utility and enhance patient outcomes, driving market growth.
3. Increased Adoption of Minimally Invasive Procedures: Patients and physiciansÄX%$%X growing preference for less invasive therapies is fueling the adoption of percutaneous devices. pMCS presents a less invasive option compared to surgical circulatory support, and this results in shorter recovery periods and possible complications.
4. Growing Awareness and Acceptance Among Clinicians: With growing clinical experience and evidence of the advantages of pMCS in different settings, there is an increasing awareness and acceptance of these devices among cardiologists and critical care specialists, resulting in greater use.
5. Positive Reimbursement Policies in Developed Countries: Positive reimbursement policies in most developed countries make patient access to pMCS treatments easier, leading to increased adoption of these technologies by hospitals and healthcare providers, thus propelling market growth.
Challenges in the percutaneous mechanical circulatory support device market are:
1. Exorbitant Cost of Devices and Procedures: The high cost of pMCS devices and the associated implantation procedures poses a significant obstacle to widespread adoption, especially in resource-constrained environments. Cost-effectiveness studies and cost-cutting strategies are vital for increased accessibility.
2. Risk of Device-Related Complications: Despite progress, pMCS devices are still linked to possible complications like bleeding, vascular damage, thrombosis, and infection. Minimizing these risks via enhanced device design, implantation techniques, and patient management algorithms is an ongoing challenge.
3. Limited Long-Term Clinical Data: While short-term benefits of pMCS are more apparent, robust long-term clinical data on patient outcomes across various applications is still unfolding. More research has to be conducted to identify optimal patient selection criteria and the long-term effects of such devices on survival and quality of life.
The interplay among these drivers and challenges greatly defines the percutaneous mechanical circulatory support device market. Whereas growth is promoted by increasing disease burden of cardiovascular disease and technical innovations, cost and possible complications remain major limiting factors requiring ongoing research efforts for device safety improvement, cost savings, and for showing long-term clinical benefit. These challenges need to be tackled to ensure ongoing growth and proper integration of pMCS in the standard treatment for patients suffering from severe cardiac dysfunction.
List of Percutaneous Mechanical Circulatory Support Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies percutaneous mechanical circulatory support device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the percutaneous mechanical circulatory support device companies profiled in this report include-
• Medtronic
• Abbott Laboratories
• LivaNova
• Eurosets
• Jarvik Heart
• Cardiobridge
• Getinge
• ABIOMED
• Teleflex Incorporated
• Berlin Heart
Percutaneous Mechanical Circulatory Support Device Market by Segment
The study includes a forecast for the global percutaneous mechanical circulatory support device market by type, size, application, end use, and region.
Percutaneous Mechanical Circulatory Support Device Market by Type [Value from 2019 to 2031]:
• Vertical Balers
• Horizontal Balers
• Two-Ram Balers
• Combination Balers
Percutaneous Mechanical Circulatory Support Device Market by Size [Value from 2019 to 2031]:
• Small Bales
• Medium Bales
• Large Bales
Percutaneous Mechanical Circulatory Support Device Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Percutaneous Mechanical Circulatory Support Device Market
The percutaneous mechanical circulatory support device market is a dynamic space with ongoing developments focused on enhancing patient outcomes for acute heart failure and cardiogenic shock. Current developments in major geographies indicate a trend towards less invasive and more efficient solutions for hemodynamic support, either as a bridge to recovery or transplant, or as destination therapy. These developments are important in the management of critically ill patients where native cardiac function is severely impaired.
• United States: The US market has witnessed growing use of Impella devices, especially in high-risk percutaneous coronary interventions (PCI). Real-world experience and registries are directly influencing the perception of optimal pMCS utilization, though controversies persist over patient selection and advantages versus procedural complications. There is emphasis on optimizing protocols for early pMCS in cardiogenic shock to enhance survival.
• China: Although still in its infancy phase relative to the rest of the world, China is actively developing and designing most MCS devices such as pulsatile, rotary, and total artificial hearts. Short-term support devices produced locally are used clinically, and studies in more sophisticated implantable pumps continue. The market is expected to expand considerably based on an emerging geriatric population and growing incidence of cardiovascular diseases.
• Germany: Germany, with its robust healthcare system and emphasis on innovation, is a prime market for pMCS devices. ThereÄX%$%Xs a focus on assessing the efficacy of diverse support strategies, such as V-A ECMO, in different clinical contexts such as high-risk PCI and cardiogenic shock. The focus of research is on reducing complications related to pMCS, including acute kidney injury and bleeding.
• India: The application of temporary mechanical circulatory support (TMCS) devices is still low despite the heavy burden of cardiogenic shock. Nevertheless, there is an increasing awareness of their ability to stabilize critically ill patients and act as a bridge to more definitive treatments such as heart transplant. There are ongoing efforts to enhance the management of cardiogenic shock through early TMCS device application.
• Japan: Japan possesses a well-established national registry for percutaneous and implantable left ventricular assist devices (LVADs), such as Impella pumps. Peripheral ECMO is widely utilized for acute MCS. New developments involve the approval of new centrifugal pumps for mid-term extracorporeal support, demonstrating a focus on developing MCS therapies.
Features of the Global Percutaneous Mechanical Circulatory Support Device Market
Market Size Estimates: Percutaneous mechanical circulatory support device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Percutaneous mechanical circulatory support device market size by various segments, such as by type, size, application, end use, and region in terms of value ($B).
Regional Analysis: Percutaneous mechanical circulatory support device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, size, application, end use, and regions for the percutaneous mechanical circulatory support device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the percutaneous mechanical circulatory support device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for percutaneous mechanical circulatory support device market?
Answer: The global percutaneous mechanical circulatory support device market is expected to grow with a CAGR of 9.2% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the percutaneous mechanical circulatory support device market?
Answer: The major drivers for this market are the increasing cases of cardiac disorders, the rising demand for minimally invasive treatments, and the growing investment in healthcare infrastructure.
Q3. What are the major segments for percutaneous mechanical circulatory support device market?
Answer: The future of the percutaneous mechanical circulatory support device market looks promising with opportunities in the retail, automotive, food & beverage, pharmaceutical, and consumer goods markets.
Q4. Who are the key percutaneous mechanical circulatory support device market companies?
Answer: Some of the key percutaneous mechanical circulatory support device companies are as follows:
• Medtronic
• Abbott Laboratories
• LivaNova
• Eurosets
• Jarvik Heart
• Cardiobridge
• Getinge
• ABIOMED
• Teleflex Incorporated
• Berlin Heart
Q5. Which percutaneous mechanical circulatory support device market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, vertical baler is expected to witness the highest growth over the forecast period.
Q6. In percutaneous mechanical circulatory support device market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the percutaneous mechanical circulatory support device market by type (vertical balers, horizontal balers, two-ram balers, and combination balers), size (small bales, medium bales, and large bales), application (plastic recycling, manufacturing waste management, commercial waste management, construction & demolition waste, and others), end use (retail, automotive, food & beverage, pharmaceuticals, consumer goods, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Percutaneous Mechanical Circulatory Support Device Market, Percutaneous Mechanical Circulatory Support Device Market Size, Percutaneous Mechanical Circulatory Support Device Market Growth, Percutaneous Mechanical Circulatory Support Device Market Analysis, Percutaneous Mechanical Circulatory Support Device Market Report, Percutaneous Mechanical Circulatory Support Device Market Share, Percutaneous Mechanical Circulatory Support Device Market Trends, Percutaneous Mechanical Circulatory Support Device Market Forecast, Percutaneous Mechanical Circulatory Support Device Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.